Back to search results

Selinexor in Combination With MTX+Ritu to Treat R/R CNSL

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Central Nervous System Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • The First Affiliated Hospital Of Anhui Medical University, Hefei, Anhui, China

    Contact: Study coordinator (Jian Ge, Ph.D)

  • Beijing Tiantan Hospital, Capital Medical University, Beijing, Beijing Municipality, China

    Contact: Study coordinator (Wenbin Li, Ph.D) · neure55@126.com · +8615301377998

  • The First Affiliated Hospital Of Fujian Medical University, Fuzhou, Fujian, China

    Contact: Study coordinator (Zhiyong Zeng, Ph.D)

  • Oncology Department of The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China

    Contact: Study coordinator (Mingzhi Zhang, PhD) · mingzhi_zhang@126.com · 13838565629
    Contact: Principal Investigator (Mingzhi Zhang, PhD)

  • Department of Hematology, Huashan Hospital, Fudan University, Shanghai, Shanghai Municipality, China

    Contact: Study coordinator (Tong Chen) · chentong@fudan.edu.cn · +862152887102
    Contact: Study coordinator (Yan Yuan) · yuanyan@fudan.edu.cn · +862152888283
Study leads

  • Tong Chen, Ph.D

    Principal Investigator

    Huashan Hospital

View source on ClinicalTrials.gov(opens in a new tab)